Product Information
GALANTAMINE ER 8 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.7939 per EA under NDC 65862074430. Its NADAC has been published 495 times since Mar 1, 2017.
FDA first approved this application on Aug 5, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Galantamine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
8 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862074430
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
GALANTAMINE HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204895FDA Approved
8/5/2016
TE Code
AB
On Market Since
8/5/2016
Pharmacological Classes
Price Statistics
The NADAC for GALANTAMINE ER 8 MG CAPSULE has been published 495 times since Mar 1, 2017, and over the history we have for it it has declined 52.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7939 per EA |
|---|---|
| All-time high | $2.2671 (Sep 11, 2019) |
| All-time low | $0.6790 (May 22, 2024) |
| 52-week high | $0.9246 |
| 52-week low | $0.7782 |
| Median price | $1.2318 |
| Average price | $1.2860 |
| Largest weekly change | +84.5% (Jul 21, 2021) |
| Weeks tracked | 495 |
| Tracking since | Mar 1, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Galantamine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GALANTAMINE ER 8 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GALANTAMINE ER 8 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.7939 per EA (NDC 65862074430), effective Aug 19, 2026.
How has the price of GALANTAMINE ER 8 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GALANTAMINE ER 8 MG CAPSULE has declined 52.7%. It has been tracked across 495 weekly CMS publications since Mar 1, 2017.
What are the highest and lowest recorded NADAC prices for GALANTAMINE ER 8 MG CAPSULE?
Since Mar 1, 2017, the NADAC for GALANTAMINE ER 8 MG CAPSULE has ranged from a low of $0.6790 (May 22, 2024) to a high of $2.2671 (Sep 11, 2019), with a median of $1.2318 per EA.
Are there cheaper alternatives to GALANTAMINE ER 8 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of GALANTAMINE ER 8 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GALANTAMINE ER 8 MG CAPSULE?
GALANTAMINE ER 8 MG CAPSULE (NDC 65862074430) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.